AKBA logo

Akebia Therapeutics, Inc. (AKBA) Retained earnings

annual retained earnings:

-$1.68B-$69.41M(-4.31%)
December 31, 2024

Summary

  • As of today (September 15, 2025), AKBA annual retained earnings is -$1.68 billion, with the most recent change of -$69.41 million (-4.31%) on December 31, 2024.
  • During the last 3 years, AKBA annual retained earnings has fallen by -$215.56 million (-14.74%).
  • AKBA annual retained earnings is now -3382.66% below its all-time high of -$48.19 million, reached on December 1, 2011.

Performance

AKBA Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAbalance sheet metrics

quarterly retained earnings:

-$1.67B+$247.00K(+0.01%)
June 1, 2025

Summary

  • As of today (September 15, 2025), AKBA quarterly retained earnings is -$1.67 billion, with the most recent change of +$247.00 thousand (+0.01%) on June 1, 2025.
  • Over the past year, AKBA quarterly retained earnings has dropped by -$36.48 million (-2.23%).
  • AKBA quarterly retained earnings is now -2705.93% below its all-time high of -$59.59 million, reached on December 1, 2012.

Performance

AKBA quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

AKBA Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.3%-2.2%
3 y3 years-14.7%-11.9%
5 y5 years-111.4%-62.2%

AKBA Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-14.7%at low-11.9%+0.4%
5 y5-year-111.4%at low-62.2%+0.4%
alltimeall time-3382.7%at low-2705.9%+0.4%

AKBA Retained earnings History

DateAnnualQuarterly
Jun 2025
-
-$1.67B(-0.0%)
Mar 2025
-
-$1.67B(-0.4%)
Dec 2024
-$1.68B(+4.3%)
-$1.68B(+1.4%)
Sep 2024
-
-$1.66B(+1.2%)
Jun 2024
-
-$1.64B(+0.5%)
Mar 2024
-
-$1.63B(+1.1%)
Dec 2023
-$1.61B(+3.3%)
-$1.61B(-0.0%)
Sep 2023
-
-$1.61B(+0.9%)
Jun 2023
-
-$1.60B(+1.0%)
Mar 2023
-
-$1.58B(+1.4%)
Dec 2022
-$1.56B(+6.4%)
-$1.56B(+0.8%)
Sep 2022
-
-$1.55B(+3.5%)
Jun 2022
-
-$1.49B(-1.9%)
Mar 2022
-
-$1.52B(+4.1%)
Dec 2021
-$1.46B(+24.2%)
-$1.46B(+5.3%)
Sep 2021
-
-$1.39B(+4.5%)
Jun 2021
-
-$1.33B(+6.7%)
Mar 2021
-
-$1.25B(+5.9%)
Dec 2020
-$1.18B(+48.3%)
-$1.18B(+8.0%)
Sep 2020
-
-$1.09B(+5.8%)
Jun 2020
-
-$1.03B(+20.6%)
Mar 2020
-
-$854.80M(+7.7%)
Dec 2019
-$794.05M
-$794.05M(+13.5%)
Sep 2019
-
-$699.57M(+8.5%)
Jun 2019
-
-$644.99M(+9.9%)
DateAnnualQuarterly
Mar 2019
-
-$586.82M(+14.1%)
Dec 2018
-$514.39M(+38.7%)
-$514.39M(+13.2%)
Sep 2018
-
-$454.34M(+6.1%)
Jun 2018
-
-$428.29M(+8.6%)
Mar 2018
-
-$394.23M(+6.3%)
Dec 2017
-$370.81M(+24.8%)
-$370.81M(-4.0%)
Sep 2017
-
-$386.33M(+6.4%)
Jun 2017
-
-$363.20M(+6.3%)
Mar 2017
-
-$341.68M(+15.0%)
Dec 2016
-$297.14M(+84.1%)
-$297.14M(+14.6%)
Sep 2016
-
-$259.27M(+16.3%)
Jun 2016
-
-$222.97M(+19.1%)
Mar 2016
-
-$187.19M(+16.0%)
Dec 2015
-$161.39M(+60.3%)
-$161.39M(+14.0%)
Sep 2015
-
-$141.53M(+16.0%)
Jun 2015
-
-$122.06M(+9.6%)
Mar 2015
-
-$111.37M(+10.6%)
Dec 2014
-$100.67M(-20.8%)
-$100.67M(+11.5%)
Sep 2014
-
-$90.30M(+11.5%)
Jun 2014
-
-$80.95M(+10.4%)
Mar 2014
-
-$73.34M(-42.3%)
Dec 2013
-$127.07M(+113.3%)
-$127.07M(+113.3%)
Dec 2012
-$59.59M(+23.6%)
-
Dec 2012
-
-$59.59M
Dec 2011
-$48.19M
-

FAQ

  • What is Akebia Therapeutics, Inc. annual retained earnings?
  • What is the all time high annual retained earnings for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. annual retained earnings year-on-year change?
  • What is Akebia Therapeutics, Inc. quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. quarterly retained earnings year-on-year change?

What is Akebia Therapeutics, Inc. annual retained earnings?

The current annual retained earnings of AKBA is -$1.68B

What is the all time high annual retained earnings for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high annual retained earnings is -$48.19M

What is Akebia Therapeutics, Inc. annual retained earnings year-on-year change?

Over the past year, AKBA annual retained earnings has changed by -$69.41M (-4.31%)

What is Akebia Therapeutics, Inc. quarterly retained earnings?

The current quarterly retained earnings of AKBA is -$1.67B

What is the all time high quarterly retained earnings for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high quarterly retained earnings is -$59.59M

What is Akebia Therapeutics, Inc. quarterly retained earnings year-on-year change?

Over the past year, AKBA quarterly retained earnings has changed by -$36.48M (-2.23%)
On this page